SCHEMBL3025318

SCHEMBL3025318

O=C(O)C1C2CC(C(Br)C2Br)C1C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.55
POLB P06746 3/20 0.48
TDP1 Q9NUW8 2/20 0.48
TSHR P16473 3/20 0.44
LMNA P02545 4/20 0.35
KDM4E B2RXH2 2/20 0.35
PMP22 Q01453 2/20 0.35
APEX1 P27695 1/20 0.35
GMNN O75496 1/20 0.35
TFPI2 P48307 1/20 0.35
TP53 P04637 1/20 0.35
NFKB1 P19838 1/20 0.35
THPO P40225 1/20 0.35
GRM2 Q14416 3/20 0.33
GRM3 Q14832 3/20 0.33
CYP2D6 P10635 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2C19 P33261 2/20 0.33
BLM P54132 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13216614 1.00 MAPK1 (0.55) MAPK1POLBTDP1TSHRLMNA
SCHEMBL4757873 0.87 MAPK1 (0.46) MAPK1POLBTDP1TSHR
SCHEMBL432536 0.82 POLB (0.57) MAPK1POLBTDP1TSHRLMNA
SCHEMBL3425859 0.77 POLB (0.52) MAPK1POLBTDP1TSHRLMNA
SCHEMBL8844007 0.76 MAPK1 (0.36) MAPK1POLBTDP1
SCHEMBL8978055 0.76 POLB (0.57) MAPK1POLBTDP1TSHRLMNA
SCHEMBL16249737 0.74 POLB (0.50) MAPK1POLBTDP1TSHRLMNA
SCHEMBL29426398 0.74 POLB (0.50) MAPK1POLBTDP1TSHRLMNA
SCHEMBL16361417 0.72 POLB (0.48) MAPK1POLBTDP1TSHRLMNA
SCHEMBL12763440 0.72 POLB (0.48) MAPK1POLBTDP1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100210765-A1 RESIST UNDERLAYER FILM-FORMING COMPOSITION, PRODUCTION METHOD OF SEMICONDUCTOR DEVICE USING THE SAME, AND ADDITIVE FOR RESIST UNDERLAYER FILM-FORMING COMPOSITION NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210765-A1 RESIST UNDERLAYER FILM-FORMING COMPOSITION, PRODUCTION METHOD OF SEMICONDUCTOR DEVICE USING THE SAME, AND ADDITIVE FOR RESIST UNDERLAYER FILM-FORMING COMPOSITION EXOC1, EPCAM, EXOC4 MAPK1 4650/4885POLB 1243/4885TDP1 2366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.